Caenorhabditis elegans-based Model Systems for Antifungal Drug Discovery

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|13|1225-1233

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.13, 2011-05, pp. : 1225-1233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Using Caenorhabditis elegans for antimicrobial drug discovery

By Desalermos Athanasios   Muhammed Maged   Glavis-Bloom Justin   Mylonakis Eleftherios  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 6, 2011-06 ,pp. : 645-652

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic target discovery using Caenorhabditis elegans

By Link Elizabeth M   Hardiman Gary   Sluder Ann E   Johnson Carl D   Liu Leo X  

Pharmacogenomics, Vol. 1, Iss. 2, 2000-05 ,pp. : 203-217

Future Medicine

Access to resources Recommend Favorite

C. elegans: An All in One Model for Antimicrobial Drug Discovery

By  

Current Drug Targets, Vol. 12, Iss. 7, 2011-06 ,pp. : 967-977

Bentham Science Publishers

Access to resources Recommend Favorite

Antifungal Drug Discovery through the Study of Invertebrate Model Hosts

By  

Current Medicinal Chemistry, Vol. 16, Iss. 13, 2009-05 ,pp. : 1588-1595

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Model System Caenorhabditis elegans and Neurodegenerative)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 8, 2012-12 ,pp. : 955-956

Bentham Science Publishers

Access to resources Recommend Favorite